host dendritic cell vaccine-001 MSSM/BIIR
Term · Oncology and biomedicine · MLC-T-ONC-014163
A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response.
| Identifier | MLC-T-ONC-014163 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MSSM/BIIR HDC Vax-001 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014163",
"term": "host dendritic cell vaccine-001 MSSM/BIIR",
"field": "Oncology and biomedicine",
"definition": "A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response.",
"synonyms": [
"MSSM/BIIR HDC Vax-001"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/host-dendritic-cell-vaccine-001-mssm-biir/"
}
Record 8,625 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.